Toutes les informations sur:

Nom	Kleis Therapeutics Limited
Adresse	Aston University Aston Triangle Birmingham B4 7ET
VAT ID (Numéro de TVA)	no VAT ID available
Société Numéro de Registre	15997787 Show on Companies House
Statut de Société	active
Fondé	4 octobre 2024
Activité (Code NAF)	72110 - Recherche-développement en biotechnologie
KYC Check KYC checks will cover 240 countries and 40 languages for both corporates and individuals: PEP - Any individual that is considered a Politically Exposed Person, from Head of State to Members of Parliament, Members of the Board of State Owned Enterprises or Ambassadors and individuals representing their countries interests abroad. Sanction - Any individual or entity that is (or was) subject to sanctions by either the European Union, the United Nations, the United States Office of Foreign Assets Control and State Department and Her Majesty’s Treasury in the United Kingdom. Financial Regulator - Any individual or entity that has been fined or in some other way subject to action by any financial regulatory body. Law Enforcement - Any individual or entity that has been named in official documentation from Law Enforcement bodies such as the Police or any other agency such as Interpol or the FBI. Also those individuals and entities cited in Court and legal documents of that nature. Adverse Media - Any individual or entity that has been reported in global newspapers, news sites or other media as being involved in financial crime. Other country specific datasets	KYC / PEP / AML request

This data is incorrect?
Source: Company Register: Companies House (companieshouse.gov.uk)

go to our Search Engine

Quick access

Persons with Significant Control
Officers
Similar VAT Registered Companies

Persons with Significant Control (2)

Source: Companies House

Griffin, Martin Status: Active Notified: 04/10/2024 Date of Birth: 04/1948 Nature of Control

Ownership of shares – More than 25% but not more than 50%

Ownership of voting rights - More than 25% but not more than 50%

Right to appoint and remove directors

Wang, Zhuo Status: Active Notified: 04/10/2024 Date of Birth: 10/1979 Nature of Control

Ownership of shares – More than 25% but not more than 50%

Ownership of voting rights - More than 25% but not more than 50%

Right to appoint and remove directors

Officers (2)

Source: Companies House

Griffin, Martin, Professor Birmingham, United Kingdom Status: Active Notified: 04/10/2024 Occupation: Lecturer Role: Director Country of Residence: England Nationality: British

Wang, Zhuo, Dr Birmingham, United Kingdom Status: Active Notified: 04/10/2024 Occupation: Lecturer Role: Director Country of Residence: United Kingdom Nationality: Chinese

Toutes les informations sur:

Kleis Therapeutics Limited

Quick access

Persons with Significant Control (2)

Officers (2)